Picture of Scinai Immunotherapeutics logo

SCNI — Scinai Immunotherapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Brief: Scinai Signs Second Amendment To Pincell Option Agreement And Submits Revised €12 Million Non-Dilutive Feng Application To Advance Pc111 Through Human Proof Of Concept

March 2 (Reuters) - Scinai Immunotherapeutics Ltd 2F5y.F:

SCINAI SIGNS SECOND AMENDMENT TO PINCELL OPTION AGREEMENT AND SUBMITS REVISED €12 MILLION NON-DILUTIVE FENG APPLICATION TO ADVANCE PC111 THROUGH HUMAN PROOF OF CONCEPT

Source text: ID:nPn15LyrZa

Further company coverage: [2F5y.F]

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Scinai Immunotherapeutics

See all news